相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Discovery of indole-piperazine derivatives as selective histone deacetylase 6 inhibitors with neurite outgrowth-promoting activities and neuroprotective activities
Ting Liang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2023)
Recent development of selective inhibitors targeting the HDAC6 as anti-cancer drugs: Structure, function and design
Jie Peng et al.
BIOORGANIC CHEMISTRY (2023)
Histone deacetylase inhibitor-based oncolytic virotherapy: A promising strategy for cancer treatment
Ekta Shirbhate et al.
DRUG DISCOVERY TODAY (2022)
The landscape of histone modifications in epigenomics since 2020
Milad Shirvaliloo
EPIGENOMICS (2022)
Histone Deacetylase Functions in Gastric Cancer: Therapeutic Target?
Amandine Badie et al.
CANCERS (2022)
A review of synthetic bioactive tetrahydro-β-carbolines: A medicinal chemistry perspective
Jiayun Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Novel 2, 5-diketopiperazine derivatives as potent selective histone deacetylase 6 inhibitors: Rational design, synthesis and antiproliferative activity
Xin Chen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Histone deacetylase 3 (HDAC3) inhibitors as anticancer agents: A review
Rajat Sarkar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Structural and in Vivo Characterization of Tubastatin A, a Widely Used Histone Deacetylase 6 Inhibitor
Sida Shen et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Discovery of 1,3-Disubstituted 2,5-Diketopiperazine Derivatives as Potent Class I HDACs Inhibitors
Guoliang Gong et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2020)
Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight
Terence C. S. Ho et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Design, synthesis and biological evaluation of novel isoindolinone derivatives as potent histone deacetylase inhibitors
Xin Chen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Selective Inhibition of Histone Deacetylase 10: Hydrogen Bonding to the Gatekeeper Residue is Implicated
Magalie Geraldy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Design, Synthesis and Biological Evaluation of Novel Benzoylimidazole Derivatives as Raf and Histone Deacetylases Dual Inhibitors
Xin Chen et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2019)
Recent advances in the discovery of potent and selective HDAC6 inhibitors
Xiu-Xiu Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Selective HDAC inhibition by ACY-241 enhances the activity of paclitaxel in solid tumor models
Pengyu Huang et al.
ONCOTARGET (2017)
Romidepsin for the treatment of relapsed/refractory cutaneous T-cell lymphoma (mycosis fungoides/Sezary syndrome): Use in a community setting
Sunil A. Reddy
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Panobinostat for the Treatment of Multiple Myeloma
Jacob P. Laubach et al.
CLINICAL CANCER RESEARCH (2015)
Optimization of a Novel Binding Motif to (E)-3-(3,5-Difluoro-4-((1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)phenyl)acrylic Acid (AZD9496), a Potent and Orally Bioavailable Selective Estrogen Receptor Downregulator and Antagonist
Chris De Savi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Anti-stress effects of ONO-2952, a novel translocator protein 18 kDa antagonist, in rats
Katsukuni Mitsui et al.
NEUROPHARMACOLOGY (2015)
Belinostat in patients with refractory or relapsed peripheral T-cell lymphoma: a perspective review
Ahmed Sawas et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2015)
Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer's disease
Nambirajan Govindarajan et al.
EMBO MOLECULAR MEDICINE (2013)
Development and Therapeutic Implications of Selective Histone Deacetylase 6 Inhibitors
Jay H. Kalin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Development of a histone deacetylase 6 inhibitor and its biological effects
Ju-Hee Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
HDAC6: Physiological function and its selective inhibitors for cancer treatment
Penghui Yang et al.
DRUG DISCOVERIES AND THERAPEUTICS (2013)
Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma
Loredana Santo et al.
BLOOD (2012)
Chidamide (CS055/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity
Zhi-Qiang Ning et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
Phase I study of chidamide (CS055/HBI-8000), a new histone deacetylase inhibitor, in patients with advanced solid tumors and lymphomas
Mei Dong et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A
Kyle V. Butler et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Spiroindolones, a Potent Compound Class for the Treatment of Malaria
Matthias Rottmann et al.
SCIENCE (2010)
HDAC family: What are the cancer relevant targets?
Olaf Witt et al.
CANCER LETTERS (2009)
被撤回的出版物: HDAC6 Modulates Hsp90 Chaperone Activity and Regulates Activation of Aryl Hydrocarbon Receptor Signaling (Retracted article. See vol. 295, pg. 297, 2020)
Vikram D. Kekatpure et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
HDAC6 modulates cell motility by altering the acetylation level of cortactin
Xiaohong Zhang et al.
MOLECULAR CELL (2007)
Dimethyl sulfoxide to vorinostat: Development of this histone deacetylase inhibitor as an anticancer drug
Paul A. Marks et al.
NATURE BIOTECHNOLOGY (2007)
Molecular evolution of the histone deacetylase family: Functional implications of phylogenetic analysis
IV Gregoretti et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
The discovery of tadalafil:: A novel and highly selective PDE5 inhibitor.: 1:: 5,6,11,11a-tetrahydro-1H-imidazo[1′,5′:1,6]pyrido[3,4-b]indole-1,3(2H)-dione analogues
A Daugan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
The discovery of tadalafil:: A novel and highly selective PDE5 inhibitor.: 2:: 2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione analogues
A Daugan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Histone deacetylases (HDACs): characterization of the classical HDAC family
AJM De Ruijter et al.
BIOCHEMICAL JOURNAL (2003)
分享论文
